Investment Analysts’ price target changes for Thursday, February 27th:
Agilent Technologies (NYSE:A) had its price target reduced by Robert W. Baird from $161.00 to $159.00. Robert W. Baird currently has an outperform rating on the stock.
Advance Auto Parts (NYSE:AAP) had its price target trimmed by Truist Financial Co. from $39.00 to $34.00. Truist Financial Co. currently has a hold rating on the stock.
Advance Auto Parts (NYSE:AAP) had its target price lowered by Royal Bank of Canada from $50.00 to $44.00. Royal Bank of Canada currently has a sector perform rating on the stock.
AerCap (NYSE:AER) had its price target boosted by Susquehanna from $108.00 to $120.00. Susquehanna currently has a positive rating on the stock.
AdaptHealth (NASDAQ:AHCO) had its price target increased by Robert W. Baird from $14.00 to $16.00. The firm currently has an outperform rating on the stock.
C3.ai (NYSE:AI) had its price target lowered by Piper Sandler from $42.00 to $28.00. They currently have a neutral rating on the stock.
C3.ai (NYSE:AI) had its target price reduced by Morgan Stanley from $32.00 to $30.00. Morgan Stanley currently has an underweight rating on the stock.
C3.ai (NYSE:AI) had its target price reduced by KeyCorp from $29.00 to $21.00. They currently have an underweight rating on the stock.
Ambarella (NASDAQ:AMBA) had its price target boosted by Needham & Company LLC from $100.00 to $110.00. They currently have a buy rating on the stock.
Ambarella (NASDAQ:AMBA) had its target price increased by Stifel Nicolaus from $95.00 to $100.00. They currently have a buy rating on the stock.
APi Group (NYSE:APG) had its price target increased by Robert W. Baird from $40.00 to $46.00. They currently have an outperform rating on the stock.
Arhaus (NASDAQ:ARHS) had its price target raised by Robert W. Baird from $12.00 to $13.00. They currently have an outperform rating on the stock.
Arcutis Biotherapeutics (NASDAQ:ARQT) had its price target increased by The Goldman Sachs Group, Inc. from $13.00 to $15.00. The firm currently has a neutral rating on the stock.
Astec Industries (NASDAQ:ASTE) had its target price boosted by Robert W. Baird from $40.00 to $41.00. Robert W. Baird currently has a neutral rating on the stock.
Alphatec (NASDAQ:ATEC) had its price target increased by Piper Sandler from $12.00 to $13.00. They currently have an overweight rating on the stock.
AvidXchange (NASDAQ:AVDX) had its price target cut by Keefe, Bruyette & Woods from $11.00 to $8.00. The firm currently has a market perform rating on the stock.
AvidXchange (NASDAQ:AVDX) had its target price reduced by Morgan Stanley from $11.00 to $8.00. Morgan Stanley currently has an equal weight rating on the stock.
AvidXchange (NASDAQ:AVDX) had its target price cut by JPMorgan Chase & Co. from $10.00 to $9.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
AvidXchange (NASDAQ:AVDX) had its price target cut by The Goldman Sachs Group, Inc. from $9.50 to $7.00. They currently have a sell rating on the stock.
AvidXchange (NASDAQ:AVDX) had its target price lowered by Robert W. Baird from $14.00 to $12.00. The firm currently has an outperform rating on the stock.
AvidXchange (NASDAQ:AVDX) had its target price cut by Wells Fargo & Company from $10.00 to $8.00. They currently have an equal weight rating on the stock.
AvidXchange (NASDAQ:AVDX) had its price target cut by BMO Capital Markets from $11.00 to $7.50. They currently have a market perform rating on the stock.
Armstrong World Industries (NYSE:AWI) had its target price boosted by Truist Financial Co. from $162.00 to $175.00. Truist Financial Co. currently has a buy rating on the stock.
Axsome Therapeutics (NASDAQ:AXSM) had its target price increased by Morgan Stanley from $125.00 to $190.00. The firm currently has an overweight rating on the stock.
Couchbase (NASDAQ:BASE) had its price target cut by The Goldman Sachs Group, Inc. from $18.00 to $16.00. They currently have a sell rating on the stock.
TopBuild (NYSE:BLD) had its target price reduced by Truist Financial Co. from $395.00 to $310.00. They currently have a hold rating on the stock.
Bloomin’ Brands (NASDAQ:BLMN) had its price target lowered by BMO Capital Markets from $16.00 to $12.00. They currently have a market perform rating on the stock.
Bloomin’ Brands (NASDAQ:BLMN) had its target price cut by The Goldman Sachs Group, Inc. from $13.00 to $10.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
Bentley Systems (NASDAQ:BSY) had its price target cut by Robert W. Baird from $60.00 to $59.00. Robert W. Baird currently has an outperform rating on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its price target increased by Truist Financial Co. from $33.00 to $35.00. They currently have a buy rating on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its target price raised by Keefe, Bruyette & Woods from $30.50 to $32.00. They currently have a market perform rating on the stock.
Beyond Meat (NASDAQ:BYND) had its target price trimmed by BMO Capital Markets from $6.00 to $5.00. BMO Capital Markets currently has a market perform rating on the stock.
Beyond Meat (NASDAQ:BYND) had its target price reduced by Barclays PLC from $4.00 to $3.00. The firm currently has an underweight rating on the stock.
Maplebear (NASDAQ:CART) had its price target boosted by Macquarie from $52.00 to $55.00. They currently have an outperform rating on the stock.
Check Point Software Technologies (NASDAQ:CHKP) had its price target boosted by Jefferies Financial Group Inc. from $250.00 to $255.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Cleveland-Cliffs (NYSE:CLF) had its target price lowered by Glj Research from $14.54 to $12.90. Glj Research currently has a buy rating on the stock.
Claros Mortgage Trust (NYSE:CMTG) had its price target reduced by Keefe, Bruyette & Woods from $4.00 to $2.50. The firm currently has an underperform rating on the stock.
Vita Coco (NASDAQ:COCO) had its target price increased by The Goldman Sachs Group, Inc. from $34.00 to $38.00. They currently have a buy rating on the stock.
Vita Coco (NASDAQ:COCO) had its target price reduced by Wells Fargo & Company from $40.00 to $39.00. The firm currently has an overweight rating on the stock.
Cogent Biosciences (NASDAQ:COGT) had its target price cut by Robert W. Baird from $10.00 to $8.00. The firm currently has a neutral rating on the stock.
Corcept Therapeutics (NASDAQ:CORT) had its price target boosted by Piper Sandler from $67.00 to $78.00. Piper Sandler currently has an overweight rating on the stock.
Core Scientific (NASDAQ:CORZ) had its target price reduced by Needham & Company LLC from $18.00 to $17.00. Needham & Company LLC currently has a buy rating on the stock.
Core Scientific (NASDAQ:CORZ) had its price target lowered by Cantor Fitzgerald from $24.00 to $21.00. They currently have an overweight rating on the stock.
Salesforce (NYSE:CRM) had its target price trimmed by Scotiabank from $440.00 to $400.00. The firm currently has a sector outperform rating on the stock.
Salesforce (NYSE:CRM) had its price target reduced by Macquarie from $370.00 to $320.00. They currently have a neutral rating on the stock.
Salesforce (NYSE:CRM) had its price target cut by Stifel Nicolaus from $425.00 to $375.00. They currently have a buy rating on the stock.
Salesforce (NYSE:CRM) had its target price cut by Robert W. Baird from $430.00 to $400.00. The firm currently has an outperform rating on the stock.
Salesforce (NYSE:CRM) had its target price lowered by BMO Capital Markets from $375.00 to $367.00. They currently have an outperform rating on the stock.
Salesforce (NYSE:CRM) had its price target lowered by Piper Sandler from $405.00 to $400.00. The firm currently has an overweight rating on the stock.
Salesforce (NYSE:CRM) had its price target trimmed by Wells Fargo & Company from $345.00 to $310.00. The firm currently has an equal weight rating on the stock.
Salesforce (NYSE:CRM) had its target price trimmed by Bank of America Co. from $440.00 to $400.00. Bank of America Co. currently has a buy rating on the stock.
Salesforce (NYSE:CRM) had its price target cut by Oppenheimer Holdings Inc. from $415.00 to $380.00. The firm currently has an outperform rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target boosted by Rosenblatt Securities from $385.00 to $450.00. Rosenblatt Securities currently has a buy rating on the stock.
Centuri (NYSE:CTRI) had its target price trimmed by Robert W. Baird from $23.00 to $22.00. They currently have an outperform rating on the stock.
CEMEX (NYSE:CX) had its price target boosted by The Goldman Sachs Group, Inc. from $8.00 to $9.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Digimarc (NASDAQ:DMRC) had its target price lowered by Needham & Company LLC from $40.00 to $30.00. The firm currently has a buy rating on the stock.
DT Midstream (NYSE:DTM) had its target price cut by Stifel Nicolaus from $106.00 to $102.00. Stifel Nicolaus currently has a buy rating on the stock.
Dycom Industries (NYSE:DY) had its price target reduced by KeyCorp from $229.00 to $201.00. The firm currently has an overweight rating on the stock.
eBay (NASDAQ:EBAY) had its target price cut by Stifel Nicolaus from $64.00 to $63.00. They currently have a hold rating on the stock.
eBay (NASDAQ:EBAY) had its price target cut by Bank of America Co. from $72.00 to $71.00. They currently have a neutral rating on the stock.
eBay (NASDAQ:EBAY) had its target price increased by Cantor Fitzgerald from $65.00 to $70.00. They currently have a neutral rating on the stock.
eBay (NASDAQ:EBAY) had its target price increased by Benchmark Co. from $65.00 to $75.00. Benchmark Co. currently has a buy rating on the stock.
eBay (NASDAQ:EBAY) had its price target boosted by BMO Capital Markets from $59.00 to $63.00. They currently have a market perform rating on the stock.
eBay (NASDAQ:EBAY) had its price target increased by Wells Fargo & Company from $61.00 to $64.00. They currently have an equal weight rating on the stock.
eBay (NASDAQ:EBAY) had its price target raised by JPMorgan Chase & Co. from $58.00 to $60.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Encore Capital Group (NASDAQ:ECPG) had its price target cut by Truist Financial Co. from $64.00 to $57.00. They currently have a buy rating on the stock.
EMCOR Group (NYSE:EME) had its price target lowered by Stifel Nicolaus from $600.00 to $514.00. Stifel Nicolaus currently has a buy rating on the stock.
Enovis (NYSE:ENOV) had its target price cut by Needham & Company LLC from $65.00 to $64.00. The firm currently has a buy rating on the stock.
EPR Properties (NYSE:EPR) had its target price increased by Stifel Nicolaus from $51.00 to $52.00. They currently have a hold rating on the stock.
Chesapeake Energy (NASDAQ:EXE) had its price target boosted by Mizuho from $128.00 to $132.00. They currently have an outperform rating on the stock.
ExlService (NASDAQ:EXLS) had its target price increased by Needham & Company LLC from $50.00 to $60.00. They currently have a buy rating on the stock.
ExlService (NASDAQ:EXLS) had its target price increased by Stifel Nicolaus from $48.00 to $54.00. Stifel Nicolaus currently has a buy rating on the stock.
Extra Space Storage (NYSE:EXR) had its target price trimmed by Royal Bank of Canada from $167.00 to $163.00. The firm currently has a sector perform rating on the stock.
National Vision (NASDAQ:EYE) had its price target boosted by Wells Fargo & Company from $12.00 to $13.00. They currently have an equal weight rating on the stock.
Shift4 Payments (NYSE:FOUR) had its price target trimmed by Morgan Stanley from $109.00 to $107.00. The firm currently has an equal weight rating on the stock.
First Solar (NASDAQ:FSLR) had its price target lowered by Morgan Stanley from $297.00 to $238.00. They currently have an overweight rating on the stock.
First Solar (NASDAQ:FSLR) had its target price cut by Guggenheim from $335.00 to $304.00. They currently have a buy rating on the stock.
Forward Air (NASDAQ:FWRD) had its price target cut by Robert W. Baird from $32.00 to $28.00. They currently have a neutral rating on the stock.
Geron (NASDAQ:GERN) had its price target trimmed by Stifel Nicolaus from $8.00 to $4.00. The firm currently has a buy rating on the stock.
Geron (NASDAQ:GERN) had its target price trimmed by Scotiabank from $6.00 to $4.00. The firm currently has a sector outperform rating on the stock.
Geron (NASDAQ:GERN) had its price target trimmed by Needham & Company LLC from $7.00 to $5.00. They currently have a buy rating on the stock.
GH Research (NASDAQ:GHRS) had its target price increased by Stifel Nicolaus from $18.00 to $32.00. Stifel Nicolaus currently has a buy rating on the stock.
Grocery Outlet (NASDAQ:GO) had its price target reduced by The Goldman Sachs Group, Inc. from $14.00 to $11.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its target price cut by Royal Bank of Canada from $7.00 to $6.00. Royal Bank of Canada currently has a sector perform rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its price target reduced by Stifel Nicolaus from $10.00 to $5.00. Stifel Nicolaus currently has a hold rating on the stock.
Hawaiian Electric Industries (NYSE:HE) had its price target raised by Wells Fargo & Company from $11.00 to $12.50. The firm currently has an equal weight rating on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its target price trimmed by HC Wainwright from $75.00 to $70.00. HC Wainwright currently has a buy rating on the stock.
Huron Consulting Group (NASDAQ:HURN) had its price target raised by Barrington Research from $142.00 to $167.00. Barrington Research currently has an outperform rating on the stock.
ICL Group (NYSE:ICL) had its price target increased by BMO Capital Markets from $6.00 to $6.50. The firm currently has a market perform rating on the stock.
International General Insurance (NASDAQ:IGIC) had its price target boosted by Royal Bank of Canada from $28.00 to $31.00. The firm currently has an outperform rating on the stock.
International General Insurance (NASDAQ:IGIC) had its price target increased by Oppenheimer Holdings Inc. from $30.00 to $32.00. The firm currently has an outperform rating on the stock.
Intuit (NASDAQ:INTU) had its target price reduced by Scotiabank from $700.00 to $600.00. They currently have a sector perform rating on the stock.
IonQ (NYSE:IONQ) had its target price lowered by Benchmark Co. from $50.00 to $45.00. They currently have a buy rating on the stock.
Itron (NASDAQ:ITRI) had its target price cut by Guggenheim from $135.00 to $133.00. They currently have a buy rating on the stock.
Itron (NASDAQ:ITRI) had its target price raised by Piper Sandler from $119.00 to $124.00. The firm currently has a neutral rating on the stock.
Ituran Location and Control (NASDAQ:ITRN) had its price target boosted by Barclays PLC from $35.00 to $50.00. They currently have an overweight rating on the stock.
Joby Aviation (NYSE:JOBY) had its price target cut by JPMorgan Chase & Co. from $6.00 to $5.00. The firm currently has an underweight rating on the stock.
Keysight Technologies (NYSE:KEYS) had its price target raised by Robert W. Baird from $180.00 to $190.00. Robert W. Baird currently has an outperform rating on the stock.
Keros Therapeutics (NASDAQ:KROS) had its price target reduced by HC Wainwright from $47.00 to $40.00. HC Wainwright currently has a buy rating on the stock.
Keros Therapeutics (NASDAQ:KROS) had its price target reduced by Wells Fargo & Company from $28.00 to $26.00. They currently have an overweight rating on the stock.
Kratos Defense & Security Solutions (NASDAQ:KTOS) had its target price lowered by Royal Bank of Canada from $37.00 to $32.00. Royal Bank of Canada currently has an outperform rating on the stock.
Kratos Defense & Security Solutions (NASDAQ:KTOS) had its price target increased by JPMorgan Chase & Co. from $24.00 to $27.00. They currently have a neutral rating on the stock.
Lucid Group (NASDAQ:LCID) had its price target reduced by Stifel Nicolaus from $3.50 to $3.00. They currently have a hold rating on the stock.
Lineage (NASDAQ:LINE) had its price target reduced by Robert W. Baird from $76.00 to $70.00. The firm currently has an outperform rating on the stock.
Lineage (NASDAQ:LINE) had its price target trimmed by Piper Sandler from $90.00 to $75.00. They currently have an overweight rating on the stock.
Leon’s Furniture (TSE:LNF) had its price target lowered by Royal Bank of Canada from C$32.00 to C$31.00. They currently have an outperform rating on the stock.
Lantheus (NASDAQ:LNTH) had its price target boosted by Truist Financial Co. from $120.00 to $127.00. They currently have a buy rating on the stock.
Lowe’s Companies (NYSE:LOW) had its price target lowered by Piper Sandler from $307.00 to $296.00. The firm currently has an overweight rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price lowered by Mizuho from $305.00 to $300.00. They currently have an outperform rating on the stock.
Lowe’s Companies (NYSE:LOW) had its price target reduced by Bank of America Co. from $305.00 to $290.00. Bank of America Co. currently has a buy rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price reduced by Truist Financial Co. from $308.00 to $295.00. They currently have a buy rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price cut by Royal Bank of Canada from $292.00 to $285.00. Royal Bank of Canada currently has a sector perform rating on the stock.
LegalZoom.com (NASDAQ:LZ) had its target price boosted by Barclays PLC from $8.00 to $9.00. They currently have an equal weight rating on the stock.
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its target price increased by HC Wainwright from $400.00 to $405.00. HC Wainwright currently has a buy rating on the stock.
MidCap Financial Investment (NASDAQ:MFIC) had its price target cut by Wells Fargo & Company from $15.00 to $14.00. They currently have an overweight rating on the stock.
Magnite (NASDAQ:MGNI) had its target price increased by Benchmark Co. from $21.00 to $25.00. The firm currently has a buy rating on the stock.
Magnite (NASDAQ:MGNI) had its target price boosted by Susquehanna from $16.00 to $22.00. Susquehanna currently has a positive rating on the stock.
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by Robert W. Baird from $50.00 to $55.00. They currently have an outperform rating on the stock.
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its price target boosted by Needham & Company LLC from $62.00 to $66.00. They currently have a buy rating on the stock.
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its target price reduced by The Goldman Sachs Group, Inc. from $82.00 to $73.00. They currently have a buy rating on the stock.
Marqeta (NASDAQ:MQ) had its price target increased by The Goldman Sachs Group, Inc. from $4.00 to $4.50. They currently have a neutral rating on the stock.
MYR Group (NASDAQ:MYRG) had its price target trimmed by Robert W. Baird from $201.00 to $159.00. Robert W. Baird currently has an outperform rating on the stock.
NewAmsterdam Pharma (NASDAQ:NAMS) had its target price raised by Scotiabank from $47.00 to $52.00. They currently have a sector outperform rating on the stock.
NewAmsterdam Pharma (NASDAQ:NAMS) had its price target lowered by Needham & Company LLC from $46.00 to $42.00. Needham & Company LLC currently has a buy rating on the stock.
NRG Energy (NYSE:NRG) had its target price boosted by Guggenheim from $134.00 to $145.00. They currently have a buy rating on the stock.
NRG Energy (NYSE:NRG) had its target price raised by Wells Fargo & Company from $140.00 to $165.00. They currently have an overweight rating on the stock.
Nutanix (NASDAQ:NTNX) had its price target boosted by Oppenheimer Holdings Inc. from $90.00 to $100.00. They currently have an outperform rating on the stock.
Nutanix (NASDAQ:NTNX) had its target price increased by Piper Sandler from $83.00 to $88.00. The firm currently has an overweight rating on the stock.
Nutanix (NASDAQ:NTNX) had its target price raised by JPMorgan Chase & Co. from $83.00 to $90.00. They currently have an overweight rating on the stock.
Nutanix (NASDAQ:NTNX) had its price target raised by Wells Fargo & Company from $75.00 to $85.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Nutanix (NASDAQ:NTNX) had its target price raised by Needham & Company LLC from $90.00 to $92.00. The firm currently has a buy rating on the stock.
Nutanix (NASDAQ:NTNX) had its price target boosted by Royal Bank of Canada from $83.00 to $95.00. They currently have an outperform rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target increased by Bank of America Co. from $190.00 to $200.00. They currently have a buy rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target raised by Truist Financial Co. from $204.00 to $205.00. Truist Financial Co. currently has a buy rating on the stock.
Oddity Tech (NASDAQ:ODD) had its target price boosted by Barclays PLC from $42.00 to $46.00. The firm currently has an equal weight rating on the stock.
Oddity Tech (NASDAQ:ODD) had its price target raised by Bank of America Co. from $50.00 to $58.00. They currently have a buy rating on the stock.
Option Care Health (NASDAQ:OPCH) had its target price increased by Barrington Research from $33.00 to $38.00. Barrington Research currently has an outperform rating on the stock.
Old Second Bancorp (NASDAQ:OSBC) had its target price raised by Keefe, Bruyette & Woods from $22.00 to $24.00. They currently have an outperform rating on the stock.
Par Pacific (NYSE:PARR) had its target price cut by TD Cowen from $21.00 to $17.00. TD Cowen currently has a buy rating on the stock.
Par Pacific (NYSE:PARR) had its price target reduced by The Goldman Sachs Group, Inc. from $20.00 to $18.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
United Parks & Resorts (NYSE:PRKS) had its price target raised by Mizuho from $43.00 to $45.00. They currently have an underperform rating on the stock.
United Parks & Resorts (NYSE:PRKS) had its target price increased by Guggenheim from $70.00 to $72.00. The firm currently has a buy rating on the stock.
Pure Storage (NYSE:PSTG) had its target price trimmed by Bank of America Co. from $77.00 to $73.00. The firm currently has a neutral rating on the stock.
Relay Therapeutics (NASDAQ:RLAY) had its target price trimmed by The Goldman Sachs Group, Inc. from $20.00 to $18.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Relay Therapeutics (NASDAQ:RLAY) had its target price cut by Stifel Nicolaus from $27.00 to $23.00. Stifel Nicolaus currently has a buy rating on the stock.
Root (NASDAQ:ROOT) had its target price boosted by Wells Fargo & Company from $80.00 to $97.00. The firm currently has an equal weight rating on the stock.
Rush Street Interactive (NYSE:RSI) had its price target raised by Wells Fargo & Company from $14.00 to $15.00. The firm currently has an overweight rating on the stock.
Revolution Medicines (NASDAQ:RVMD) had its target price cut by Needham & Company LLC from $60.00 to $59.00. The firm currently has a buy rating on the stock.
Revolution Medicines (NASDAQ:RVMD) had its price target reduced by Stifel Nicolaus from $80.00 to $78.00. They currently have a buy rating on the stock.
Sinclair (NASDAQ:SBGI) had its price target trimmed by Wells Fargo & Company from $19.00 to $17.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Schrödinger (NASDAQ:SDGR) had its target price cut by Piper Sandler from $50.00 to $45.00. The firm currently has an overweight rating on the stock.
Sweetgreen (NYSE:SG) had its target price reduced by Oppenheimer Holdings Inc. from $41.00 to $35.00. They currently have an outperform rating on the stock.
Sweetgreen (NYSE:SG) had its target price lowered by Piper Sandler from $39.00 to $27.00. They currently have a neutral rating on the stock.
Sweetgreen (NYSE:SG) had its price target lowered by TD Securities from $45.00 to $33.00. TD Securities currently has a buy rating on the stock.
Sweetgreen (NYSE:SG) had its price target trimmed by The Goldman Sachs Group, Inc. from $37.00 to $32.00. They currently have a neutral rating on the stock.
Steven Madden (NASDAQ:SHOO) had its target price trimmed by Telsey Advisory Group from $44.00 to $38.00. Telsey Advisory Group currently has a market perform rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its price target increased by Truist Financial Co. from $54.00 to $61.00. They currently have a buy rating on the stock.
Snowflake (NYSE:SNOW) had its price target increased by Barclays PLC from $190.00 to $203.00. They currently have an overweight rating on the stock.
Snowflake (NYSE:SNOW) had its target price increased by Piper Sandler from $208.00 to $215.00. The firm currently has an overweight rating on the stock.
Snowflake (NYSE:SNOW) had its target price increased by Oppenheimer Holdings Inc. from $200.00 to $220.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Snowflake (NYSE:SNOW) had its target price raised by Monness Crespi & Hardt from $188.00 to $230.00. They currently have a buy rating on the stock.
Snowflake (NYSE:SNOW) had its target price boosted by Needham & Company LLC from $200.00 to $215.00. They currently have a buy rating on the stock.
Snowflake (NYSE:SNOW) had its price target boosted by Wells Fargo & Company from $210.00 to $215.00. The firm currently has an overweight rating on the stock.
Snowflake (NYSE:SNOW) had its price target raised by Royal Bank of Canada from $210.00 to $221.00. They currently have an outperform rating on the stock.
Snowflake (NYSE:SNOW) had its price target boosted by KeyCorp from $210.00 to $220.00. The firm currently has an overweight rating on the stock.
Snowflake (NYSE:SNOW) had its target price increased by Cantor Fitzgerald from $201.00 to $228.00. The firm currently has an overweight rating on the stock.
Snowflake (NYSE:SNOW) had its price target raised by Stifel Nicolaus from $187.00 to $210.00. They currently have a buy rating on the stock.
Synopsys (NASDAQ:SNPS) had its target price trimmed by Wells Fargo & Company from $540.00 to $520.00. They currently have an equal weight rating on the stock.
Synopsys (NASDAQ:SNPS) had its price target trimmed by Piper Sandler from $655.00 to $653.00. They currently have an overweight rating on the stock.
Sarepta Therapeutics (NASDAQ:SRPT) had its price target lowered by Royal Bank of Canada from $165.00 to $161.00. Royal Bank of Canada currently has an outperform rating on the stock.
TaskUs (NASDAQ:TASK) had its target price boosted by Royal Bank of Canada from $18.00 to $20.00. Royal Bank of Canada currently has a sector perform rating on the stock.
Taboola.com (NASDAQ:TBLA) had its target price lowered by Needham & Company LLC from $5.00 to $4.00. They currently have a buy rating on the stock.
Teladoc Health (NYSE:TDOC) had its price target lowered by Piper Sandler from $13.00 to $12.00. They currently have an overweight rating on the stock.
TJX Companies (NYSE:TJX) had its target price increased by BMO Capital Markets from $133.00 to $145.00. They currently have an outperform rating on the stock.
TJX Companies (NYSE:TJX) had its price target raised by Robert W. Baird from $138.00 to $140.00. They currently have an outperform rating on the stock.
TJX Companies (NYSE:TJX) had its price target increased by Barclays PLC from $136.00 to $137.00. The firm currently has an overweight rating on the stock.
TKO Group (NYSE:TKO) had its target price increased by Guggenheim from $170.00 to $175.00. Guggenheim currently has a buy rating on the stock.
Tandem Diabetes Care (NASDAQ:TNDM) had its target price trimmed by Robert W. Baird from $37.00 to $33.00. Robert W. Baird currently has a neutral rating on the stock.
Tandem Diabetes Care (NASDAQ:TNDM) had its price target cut by Royal Bank of Canada from $65.00 to $55.00. The firm currently has an outperform rating on the stock.
Trinity Capital (NASDAQ:TRIN) had its price target boosted by Keefe, Bruyette & Woods from $15.00 to $16.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its target price reduced by Guggenheim from $205.00 to $200.00. The firm currently has a buy rating on the stock.
Universal Health Services (NYSE:UHS) had its price target reduced by Barclays PLC from $271.00 to $249.00. Barclays PLC currently has an overweight rating on the stock.
Urban Outfitters (NASDAQ:URBN) had its target price boosted by Telsey Advisory Group from $56.00 to $59.00. They currently have a market perform rating on the stock.
Urban Outfitters (NASDAQ:URBN) had its target price increased by Robert W. Baird from $60.00 to $62.00. The firm currently has a neutral rating on the stock.
Urban Outfitters (NASDAQ:URBN) had its price target raised by Wells Fargo & Company from $60.00 to $65.00. The firm currently has an equal weight rating on the stock.
Marriott Vacations Worldwide (NYSE:VAC) had its target price trimmed by Stifel Nicolaus from $112.00 to $108.00. The firm currently has a buy rating on the stock.
Vera Therapeutics (NASDAQ:VERA) had its target price raised by Guggenheim from $59.00 to $61.00. The firm currently has a buy rating on the stock.
Verisk Analytics (NASDAQ:VRSK) had its price target increased by Robert W. Baird from $298.00 to $320.00. The firm currently has an outperform rating on the stock.
Verisk Analytics (NASDAQ:VRSK) had its price target boosted by BMO Capital Markets from $280.00 to $297.00. BMO Capital Markets currently has a market perform rating on the stock.
Verisk Analytics (NASDAQ:VRSK) had its price target lowered by Wells Fargo & Company from $325.00 to $321.00. Wells Fargo & Company currently has an overweight rating on the stock.
Workday (NASDAQ:WDAY) had its target price boosted by BMO Capital Markets from $300.00 to $314.00. The firm currently has an outperform rating on the stock.
Essential Utilities (NYSE:WTRG) had its price target raised by Wells Fargo & Company from $39.00 to $41.00. The firm currently has an equal weight rating on the stock.
Clear Secure (NYSE:YOU) had its price target lowered by Stifel Nicolaus from $32.00 to $26.00. The firm currently has a hold rating on the stock.
Zeta Global (NYSE:ZETA) had its target price cut by Barclays PLC from $32.00 to $18.00. They currently have an equal weight rating on the stock.
Zoetis (NYSE:ZTS) had its price target increased by Piper Sandler from $200.00 to $205.00. They currently have an overweight rating on the stock.
Zevia PBC (NYSE:ZVIA) had its price target cut by Telsey Advisory Group from $4.00 to $3.00. The firm currently has a market perform rating on the stock.
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
